Mahon Paul A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Oct 10, 2023
- Accession no.
- 0001415889-23-014070
- Filed
- Oct 10, 2023
- Trade date
- Oct 5, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.34M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mahon Paul ACIK 0001231589 | Officer (EVP & GENERAL COUNSEL) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 5, 2023 | Common Stock | MOption exerciseAcquired | +6,000 | $117.76 | +$706,560 | 42,599 | Direct | |
| Oct 5, 2023 | Common Stock | SSaleDisposed | −374 | $221.92F2 | −$82,998.08 | 42,225 | Direct | |
| Oct 5, 2023 | Common Stock | SSaleDisposed | −2,171 | $223.34F3 | −$484,871.14 | 40,054 | Direct | |
| Oct 5, 2023 | Common Stock | SSaleDisposed | −3,155 | $224.27F4 | −$707,571.85 | 36,899 | Direct | |
| Oct 5, 2023 | Common Stock | SSaleDisposed | −300 | $224.93F5 | −$67,479 | 36,599 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 5, 2023 | Common Stock | MOption exerciseDisposed | −6,000 | $0.00 | $0 | 120,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $221.72 to $222.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $222.80 to $223.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $223.80 to $224.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $224.89 to $225.005. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.